Eosinophilia Induced by Biosimilar Adalimumab (CinnoRA) in a Patient with Psoriasis and Psoriatic Arthritis: A Case Report
This case illustrates that unexplained eosinophilia can occur during TNF-alpha inhibitor therapy. While routine monitoring is not universally recommended based on a single case, clinicians should consider eosinophilia as a possible adverse reaction, especially in symptomatic patients or those with persistently elevated counts.
Authors
- Alireza Firooz (ORCID: https://orcid.org/0000-0001-7274-4840)
- Roya Saedpanah
- A Rashidi
Institutions
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Cosmetic and Investigational Dermatology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/ccid.s546208
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00